<DOC>
	<DOCNO>NCT00001100</DOCNO>
	<brief_summary>The purpose study evaluate benefit safety antiviral drug ganciclovir ( DHPG ) give intravenously treat newborn infant bear infected cytomegalovirus ( CMV ) . CMV herpes virus infect organ body , result death 10-30 % baby symptoms CMV . It cause severe brain damage large percentage survive baby . Children study CMV infection central nervous system ( CNS ) .</brief_summary>
	<brief_title>A Phase III Study Evaluate Safety Efficacy Ganciclovir ( Dihydroxypropoxymethyl Guanine DHPG ) Treatment Symptomatic Central Nervous System ( CNS ) Congenital Cytomegalovirus ( CMV ) Infections .</brief_title>
	<detailed_description>The study enroll 130 newborn infant 1 month age young CMV involve CNS . Patients assign randomly ( like toss coin ) receive either DHPG study drug treatment . All baby study receive standard care treatment clinical , diagnostic , laboratory , safety , follow-up evaluation . Follow-up evaluation , include hear eye exam developmental assessment , do periodically child reach 5 year age . The degree improve hearing among survive patient primary measure drug effectiveness .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Cytomegalovirus Infections</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<criteria>Infants may eligible study : Were full term infant ( least 32 week gestation ) . Are 1 month age younger ( preferably less 2 week ) . Weighed least 1,200 gram ( 2.5 lb ) birth . Have confirm cytomegalovirus . Have evidence CMV infection CNS without evidence organ involvement . Infants eligible study : Have concurrent bacterial infection . Have HIV infection . Have mild symptom symptom CMV infection birth . Have abnormal brain development ( hydranencephaly ) devastate brain involvement .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Month</maximum_age>
	<verification_date>November 2005</verification_date>
</DOC>